{
    "clinical_study": {
        "@rank": "95719", 
        "arm_group": {
            "arm_group_label": "Myofascial trigger point injection", 
            "arm_group_type": "Other", 
            "description": "Myofascial trigger point injection on gastrocnemius muscle"
        }, 
        "brief_summary": {
            "textblock": "Nocturnal leg cramps is involuntary strong contraction of leg muscle, mostly in calves. It\n      occurs suddenly and induces pain. Patients with frequent nocturnal leg cramps suffer from\n      sleep disturbance in company with pain. In the present study, we examined the effects of the\n      myofascial trigger point injections, which are known to be helpful for ease of nocturnal leg\n      cramps, on pain and sleep disturbance in patients with nocturnal leg cramps with trigger\n      points on gastrocnemius muscle."
        }, 
        "brief_title": "The Effects of the Myofascial Trigger Point Injections on Pain and Sleep Disturbance in Patients With Nocturnal Leg Cramps With Trigger Points on Gastrocnemius Muscle", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Nocturnal Leg Cramps", 
        "condition_browse": {
            "mesh_term": [
                "Muscle Cramp", 
                "Sleep-Wake Transition Disorders", 
                "Sleep Disorders", 
                "Dyssomnias", 
                "Parasomnias"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients (20-80 years of age) scheduled for myofascial trigger point injections\n             on gastrocnemius muscle due to nocturnal leg cramps at least once a week\n\n        Exclusion Criteria:\n\n          -  Patients with no trigger points on gastrocnemius muscle,\n\n          -  electrolyte abnormality,\n\n          -  congenital musculoskeletal disorder,\n\n          -  local or systemic infection, bleeding disorder or the use of anticoagulation\n             medications,\n\n          -  known allergy of local anesthetics, or the use of hypnotics or sedatives in the last\n             1 month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "13", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804556", 
            "org_study_id": "4-2012-0197"
        }, 
        "intervention": {
            "arm_group_label": "Myofascial trigger point injection", 
            "description": "On the first visit (T0), we record numeric rating scale (NRS), the frequency of cramps and insomnia severity index using questionnaires. Then we check trigger points of gastrocnemius muscle and inject lidocaine 1 ~ 2 ml each up to four points. One week later (T1) we record numeric rating scale (NRS), the frequency of cramps and insomnia severity index again, check trigger points, and if any, inject lidocaine. If the patient do not come, we get numeric rating scale (NRS), the frequency of cramps and insomnia severity index over the telephone. Two weeks after the first visit (T2), we repeat the procedure of the first visit (T0). And four weeks after the first visit (T3) we record numeric rating scale (NRS), the frequency of cramps and insomnia severity index through face-to-face interview or by telephone.", 
            "intervention_name": "Myofascial trigger point injections on gastrocnemius muscle", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "muscle cramps, trigger points, sleep disturbance", 
        "lastchanged_date": "March 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain score measured by numeric rating scale", 
            "measure": "Pain score", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "reference": {
            "PMID": "15710025", 
            "citation": "Al-Shaikh B, George William M, Van Zundert AA. Using atmospheric pressure to inflate the cuff of the Portex Laryngeal Mask. Anaesthesia. 2005 Mar;60(3):296-7."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804556"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}